HCW Biologics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1.23	1.95	4.67	3.6	22.33	11.73
Short-Term Investments	-	-	-	-	9.74	24.98
Cash & Short-Term Investments	1.23	1.95	4.67	3.6	32.06	36.71
Cash Growth	10.95%	-58.23%	30.03%	-88.79%	-12.67%	334.19%
Accounts Receivable	0.07	0.03	0.58	1.54	0.42	0.13
Other Current Assets	0.42	0.3	0.44	1.27	1.59	3.63
Total Current Assets	1.72	2.28	5.7	6.4	34.07	40.48
Net Property, Plant & Equipment	20.77	20.88	22.91	20.45	10.8	1.12
Long-Term Investments	4.83	1.33	1.6	1.6	1.6	11.52
Other Long-Term Assets	0.03	0.03	0.03	0.06	0.33	0.39
Total Assets	27.34	24.52	30.24	28.51	46.81	53.51
Accounts Payable	11.79	13.14	22.33	6.17	1.23	0.22
Accrued Expenses	1.13	1.11	0.98	2.58	1.73	2.1
Short-Term Debt	6.58	6.81	6.31	-	-	-
Unearned Revenue	0.47	-	-	-	-	-
Total Current Liabilities	19.96	21.06	29.63	8.75	2.96	2.32
Long-Term Debt	-	-	7.38	6.3	6.41	-
Other Long-Term Liabilities	1.62	0.69	-	-	0.01	-
Total Long-Term Liabilities	1.62	0.69	7.38	6.3	6.42	-
Total Liabilities	21.58	21.76	37.01	15.05	9.38	2.32
Common Stock	0	0	0	0	0	0
Additional Paid-in Capital	110.81	111.28	93.79	83.99	82.96	81.83
Retained Earnings	-105.04	-108.52	-100.56	-70.53	-45.54	-30.64
Total Common Shareholders' Equity	5.76	2.76	-6.77	13.46	37.43	51.19
Shareholders' Equity	5.76	2.76	-6.77	13.46	37.43	51.19
Total Liabilities & Equity	27.34	24.52	30.24	28.51	46.81	53.51
Total Debt	6.58	6.81	13.69	6.3	6.41	0
Net Cash (Debt)	-5.35	-4.86	-9.02	-2.71	25.65	36.71
Net Cash Growth	-	-	-	-	-30.13%	334.19%
Net Cash Per Share	-1.67	-2.31	-9.30	-3.02	28.64	78.24
Book Value	5.76	2.76	-6.77	13.46	37.43	51.19
Book Value Per Share	1.79	1.32	-6.98	14.99	41.79	109.09
Tangible Book Value	5.76	2.76	-6.77	13.46	37.43	51.19
Tangible Book Value Per Share	1.79	1.32	-6.98	14.99	41.79	109.09

SEC Filings: 10-K · 10-Q